BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9373912)

  • 1. Flow cytometric evaluation of transferrin receptor in transitional cell carcinoma.
    Rahman SA; Yokoyama M; Nishio S; Takeuchi M
    Urol Res; 1997; 25(5):325-9. PubMed ID: 9373912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA-Flow cytometric analysis of bladder TCC using paraffin-embedded tissues.
    Wu L; Lochhead A; Yang J; Ow KT; Russell PJ
    Urol Int; 1998 Aug; 60(4):208-15. PubMed ID: 9701732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reappraisal of the biological role of epidermal growth factor receptor in transitional cell carcinoma.
    Chow NH; Tzai TS; Lin SN; Chan SH; Tang MJ
    Eur Urol; 1993; 24(1):140-3. PubMed ID: 8365434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA ploidy as a prognostic factor in muscle invasive transitional cell carcinoma of the bladder.
    Deliveliotis C; Georgoulakis J; Skolarikos A; Trakas N; Varkarakis J; Albanis S; Protogerou B; Bamias A
    Urol Res; 2005 Feb; 33(1):39-43. PubMed ID: 15258707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of DNA ploidy levels with altered cytokeratin patterns in rat bladder tumors.
    Reedy EA; Cottrell JR; Resau JH
    Pathobiology; 1991; 59(2):62-8. PubMed ID: 1713770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA aberrations in urinary bladder cancer detected by flow cytometry and FISH: prognostic implications.
    Cianciulli AM; Bovani R; Leonardo C; Iori F; Coletta AM; Marzano R; Antenucci A; Gandolfo GM; Laurenti C
    Eur J Histochem; 2001; 45(1):65-71. PubMed ID: 11411867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deoxyribonucleic acid content and survival rates of patients with transitional cell carcinoma of the bladder.
    al-Abadi H; Nagel R
    J Urol; 1994 Jan; 151(1):37-42. PubMed ID: 8254829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratumoral heterogeneity in DNA ploidy of bladder carcinomas.
    Sasaki K; Hamano K; Kinjo M; Hara S
    Oncology; 1992; 49(3):219-22. PubMed ID: 1495749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of flow cytometric deoxyribonucleic acid measurements of deparaffinized specimens in bladder tumors.
    Miao T; Wang Z; Sang N; Xiong R; Cao S
    Eur Urol; 1992; 21(2):98-102. PubMed ID: 1499623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a high risk subgroup of grade 1 transitional cell carcinoma using image analysis based deoxyribonucleic acid ploidy analysis of tumor tissue.
    Hemstreet GP; Rollins S; Jones P; Rao JY; Hurst RE; Bonner RB; Hewett T; Smith BG
    J Urol; 1991 Dec; 146(6):1525-9. PubMed ID: 1942333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA ploidy of bladder cancer using bladder biopsy supernate specimens.
    Loughman NT; Lin BP; Dent OF; Newland RC
    Anal Quant Cytol Histol; 2003 Jun; 25(3):146-58. PubMed ID: 12882086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studies on nuclear DNA content in bladder cancers using flow cytometry].
    Toyota K
    Hokkaido Igaku Zasshi; 1996 Jan; 71(1):45-53. PubMed ID: 8727374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The predictive value of flow cytometry and urinary cytology in the followup of patients with transitional cell carcinoma of the bladder.
    Giella JG; Ring K; Olsson CA; Karp FS; Benson MC
    J Urol; 1992 Aug; 148(2 Pt 1):293-6. PubMed ID: 1635121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Image cytometry determination of ploidy level, proliferative activity, and nuclear size in a series of 314 transitional bladder cell carcinomas.
    van Velthoven R; Petein M; Oosterlinck WJ; Zandona C; Zlotta A; Van der Meijden AP; Pasteels JL; Roels H; Schulman C; Kiss R
    Hum Pathol; 1995 Jan; 26(1):3-11. PubMed ID: 7821913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosomal aberrations in transitional cell carcinoma: its correlation with tumor behavior.
    Yu DS; Chen HI; Chang SY
    Urol Int; 2002; 69(2):129-35. PubMed ID: 12187044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of transferrin receptor on transitional cell cancer].
    Tomita Y; Nishiyama T; Sato S; Fujiwara M
    Hinyokika Kiyo; 1991 Jan; 37(1):11-6. PubMed ID: 2011963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An immunohistochemical and prognostic evaluation of cathepsin D expression in 105 bladder carcinomas.
    Dickinson AJ; Fox SB; Newcomb PV; Persad RA; Sibley GN; Harris AL
    J Urol; 1995 Jul; 154(1):237-41. PubMed ID: 7776437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transferrin receptor expression by human bladder transitional cell carcinomas.
    Seymour GJ; Walsh MD; Lavin MF; Strutton G; Gardiner RA
    Urol Res; 1987; 15(6):341-4. PubMed ID: 3324443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometric DNA ploidy analysis in canine transitional cell carcinoma of urinary bladders.
    Clemo FA; DeNicola DB; Carlton WW; Morrison WB; Walker E
    Vet Pathol; 1994 Mar; 31(2):207-15. PubMed ID: 8203084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA content and proliferation activity in superficial transitional cell carcinoma of the bladder.
    Pantazopoulos D; Ioakim-Liossi A; Karakitsos P; Aroni K; Kakoliris S; Kanavaros P; Kyrkou KA
    Anticancer Res; 1997; 17(1B):781-6. PubMed ID: 9066620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.